Nyloxin® / Nyloxin Extra Strength®

About Nutra Pharma

Founded in 2000, Nutra Pharma Corp. (OTC: NPHC) is a biotechnology company with a dual mission: to develop innovative, non-opioid therapeutics from its proprietary cobra venom toxin platform and to commercialize accessible pain management products. Its strategy hinges on acquiring, licensing, and commercializing pharmaceutical assets for complex conditions like multiple sclerosis and HIV, while generating near-term revenue through direct-to-consumer sales of its OTC pain relievers. The company's core scientific achievement is over a decade of peer-reviewed research validating the anti-inflammatory, immunosuppressive, and analgesic properties of its lead compound, alpha-cobratoxin.

Therapeutic Areas

Other Moderate to Severe Pain Drugs